U.S. Global Investors (USGI)’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,990
Closed -$408K 183
2017
Q3
$408K Hold
1,990
0.12% 117
2017
Q2
$484K Buy
+1,990
New +$468K 0.17% 99
2015
Q3
Sell
-4,000
Closed -$1.21M 377
2015
Q2
$1.21M Hold
4,000
0.47% 62
2015
Q1
$1.19M Sell
4,000
-1,000
-20% -$285K 0.33% 80
2014
Q4
$1.29M Hold
5,000
0.35% 68
2014
Q3
$1.21M Hold
5,000
0.34% 90
2014
Q2
$1.12M Buy
+5,000
New +$1.04M 0.24% 99
2013
Q3
Sell
-5,500
Closed -$694K 359
2013
Q2
$694K Buy
+5,500
New +$623K 0.12% 139

Other funds holding AGN

U.S. Global Investors (USGI)'s AGN Position: Q4 2017 in Review

U.S. Global Investors (USGI) sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 1,990 shares — an estimated $408K sold.

U.S. Global Investors (USGI) first reported a position in AGN in Q2 2013 and held it in 8 quarters. The position peaked at $1.29M in Q4 2014. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • U.S. Global Investors (USGI) reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • U.S. Global Investors (USGI) sold 1,990 Allergan plc shares in Q4 2017, an estimated $408K.
  • U.S. Global Investors (USGI) first reported a position in Allergan plc in Q2 2013 and held it in 8 quarters.
  • U.S. Global Investors (USGI)'s Allergan plc position peaked at $1.29M in Q4 2014.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on U.S. Global Investors (USGI)'s 13F filing for Q4 2017, filed 13 Feb 2018.